Suche
Mein Konto
New incubator in Whitechapel: saving lives with innovation!
H.I.G. Capital and the Queen Mary BioEnterprises Innovation Center expand incubator space for life sciences start-ups in London.
New incubator in Whitechapel: saving lives with innovation!
A groundbreaking announcement comes to us from London: H.I.G. Capital, a leading global investment firm with $67 billion in capital under management, has entered into a strategic partnership with the Queen Mary BioEnterprises Innovation Center (QMB) in Whitechapel. This collaboration includes the provision of 40,000 square meters of incubator space with the aim of creating an international life sciences center. According to H.I.G. Managing Director Jérôme Fouillé, this project is a crucial step towards establishing a dynamic life sciences cluster in the region that will accelerate the development of innovative healthcare solutions, such as ots.at reported.
The promising partnership is also strengthened by collaboration with renowned institutions such as Barts Life Sciences, Barts Health NHS Trust and Queen Mary University of London. The planned incubator will not only create an environment for promising start-ups, but will also support long-term jobs in Whitechapel and advance life sciences training. Ted Webster, Chairman of the QMB, highlights that this initiative will make it possible to support the next generation of innovative companies and provide the necessary resources to ensure their success.
Core of the innovation center
The existing QMB incubator center, which opened in 2011 and already offers 39,000 square meters of commercial laboratories and offices, has established itself as a significant hub for biotechnology start-ups. QMB’s expertise in supporting innovative businesses will now be further strengthened with the expansion and new incubator on Cavell Street. Here, aspiring companies can find optimal conditions for growth and innovation, supported by the excellent facilities of Queen Mary University of London’s School of Medicine and Dentistry.
The commitment of life sciences professionals to focus on the commercial aspect of research is demonstrated by consultants like Betsy Golland, who bridge the gap between academic research and commercial implementation. Their focus on technology and engineering innovations, particularly in healthcare, is highlighted as key to maximizing success for research projects, as well as on qminnovation.co.uk sketched. This partnership and development aimed at strengthening London's life sciences ecosystem promises major advances in healthcare and beyond.